Investigation of the term of amlodipine storage in biological material in its putrefactive decomposition

Authors

DOI:

https://doi.org/10.24959/ubphj.17.133

Keywords:

amlodipine besylate, biological material in its putrefactive decomposition, the term of storage

Abstract

Topicality. Amlodipine besylate belongs to the group of calcium channel blockers, derivative from 1,4-dihydropyridine. The pharmacological effects of amlodipine are the cause its effectiveness in the treatment of hypertension and the vasospastic form of stenocardia. According to the literature sources, amlodipine in case of overdose can provoke the development of breast cancer, cause ischemia of the optic nerve. Deadly poisoning with amlodipine may accompany drug overdoses or suicidal cases. The development of highly sensitive and selective methods for the study of amlodipine during forensic toxicological examination of biological material is an actual task.
Aim. To develop an algorithm for the direct analysis of amlodipine in putrefactive biological material suitable for forensic toxicological examination and the study of the term of storage of the test substance.
Materials and methods. For the study, model mixtures of liver tissue with amlodipine besylate were used, which were stored at 5 °C for 1, 10, 20, 30 and 40 days. At the same time, control experiments were put. Extraction of the substance was carried out by the modified Stas-Otto method, purification was performed by extraction of impurities with diethyl ether at a pH of 2,0-3,0 and TLC method. Amlodipine was identified in biogenic extracts by the TLC method in
three mobile solvent systems. The content of the substance was determined by spectrophotometry in the UV spectral region and extraction photometry.
Results and discussion. It was found that after storage in the liver tissue, amlodipine can be isolated by the modified Stas-Otto method – 20.0-23.3 % (ε = ± 3.01-4.87 %, RSDx = 22.32-38.84 %). After 20 days of storage, 12.97 ± 5.12 % amlodipine can be detected by decay in the liver of the corpse by spectrophotometry in the UV region of the spectrum and 12.38 ± 4.68 % by extraction photometry. After 30 days, it is possible to detect amlodipine only when using spectrophotometry in the UV region of the spectrum – 6.40 ± 6.97 % of the substance, and after 40 days, it is impossible to detect amlodipine in the liver of the corpse when it rot.                                                            Conclusions. Based on the results of the research, an algorithm for directional analysis of amlodipine in putrefactive biological material was developed, suitable for forensic toxicological examination, and the term of storage of the test substance was studied. It was established that after 30 days, amlodipine can be detected only when spectrophotometry is used in the UV region of the spectrum – 6.40 ± 6.97 % of the substance; after 40 days, it is impossible to detect amlodipine in the liver of a corpse when it is rotting. The developed methods can be proposed for introduction into the practice of the Bureau of Forensic Science, toxicological centers.

Author Biographies

O. O. Mamina, National University of Pharmacy

Doctor of Pharmaceutical Sciences, professor of the Department of Physical and Colloid Chemistry

V. I. Kabachny, National University of Pharmacy

Doctor of Pharmaceutical Sciences, professor, head of the Department of Physical and Colloid Chemistry

T. O. Tomarovska, National University of Pharmacy

PhD of Pharmacy, assistant professor of the Department of Physical and Colloid Chemistry

References

Mashkovskii, M. D. (2012). Lekarstvennye sredstva: 16–e izd. Moscow: Novaia Volna, 1216.

Clarke, E. J. C. (2011). Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids and Postmortem Material. London: The Pharm. Press, 2463.

Simonyi, G., Ferenci, T., Medvegy, M., Gasparics, R., Finta, E. (2017). A perindopril/amlodipin szabad és fix kombinációk egyéves terápiahűsége.

Orvosi Hetilap, 156 (36), 1421–1425. doi: 10.1556/650.2017.30851

Simonyi, G., Ferenci, T. (2016). A ramipril/amlodipin és a lisinopril/amlodipin fix kombinációk a terápiahűség tükrében. Orvosi Hetilap, 157 (1),

–34. doi: 10.1556/650.2016.30344

Wright, C. M., Moorin, R. E., Chowdhury, E. K., Stricker, B. H., Reid, C. M., Saunders, C. M., Hughes, J. D. (2017). Calcium channel blockers and breast cancer

incidence: An updated systematic review and meta–analysis of the evidence. Cancer Epidemiology, 50,113–124. doi: 10.1016/j.canep.2017.08.012

Kao, R., Landry, Y., Chick, G., Leung, A. (2017). Bilateral blindness secondary to optic nerve ischemia from severe amlodipine overdose: a case

report. Journal Medical Case Report, 11 (1), 211. doi: 10.1186/s13256–017–1374–4

Graudins, A., Lee, H. M., Druda, D. (2016). Calcium channel antagonist and beta–blocker overdose: antidotes and adjunct therapies. British Journal

Clinical of Pharmacology, 81 (3), 453–461. doi: 10.1111/bcp.12763

Spiller, Henry A. Beth A. Milliner, George M. Bosse (2012). Amlodipine Fatality in an Infant with Postmortem Blood Levels. Journal of Medical

Toxicology, 8 (2), 179–182. doi: 10.1007/s13181–011–0207–x

El–Bagary, R. I., Elkady, E. F., Mowaka, S., Attallah, M. A. (2017). A Validated HPLC Method for Simultaneous Determination of Perindopril Arginine,

Amlodipine, and Indapamide: Application in Bulk and in Different Pharmaceutical Dosage Forms. Journal of AOAC International, 100 (4), 992–999.

doi: 10.5740/jaoacint.16–0279

Duraisamy, K., Jaganathan, K. S., Krishna, M. V. (2017). Method development and validation of HPLC tandem/mass spectrometry for quantification

of perindopril arginine and amlodipine besylate combination in bulk and pharmaceutical formulations. Research in Pharmaceutical Sciences,

(4), 307–314. doi: 10.4103/1735–5362.212048

Mohamed, H. M., Lamie, N. T. (2016). Application and validation of superior spectrophotometric methods for simultaneous determination of

ternary mixture used for hypertension management. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 155 (2), 103–110. doi:

1016/j.saa.2015.11.001

Bondar, N. M., Bondar, V. S., Mamina, O. O. (2005). Stan, perspektyvy sudovo–toksykolohichnoi sluzhby ta naukovykh doslidzhen. Kharkiv: NUPh, 35–36.

Burchynskyi, V. H., Kakhanovskyi, F. M., Kakhanovska, K. I., Khokholieva, T. V. (2010). Zahalni metody izoliuvannia otruinykh ta sylnodiiuchykh

rechovyn iz biolohichnoho materialu. Odesa: Astroprynt, 44.

Bondar, N. M., Bondar, V. S., Mamina, O. O. (2006). Aktualni pytannia farmatsevtychnoi ta medychnoi nauky ta praktyky. Zaporizhzhia: ZDMU, XV (1), 70–75.

Bondar, N. M., Bondar, V. S., Mamina, O. O. (2004). Vìsnik farmacìï, 2 (38), 18–22.

Mamina, O. O., Bondar, N. M. (2005). Farmatsevtychnyi zhurnal, 5, 87–92.

Downloads

Published

2017-10-17

Issue

No. 5(52) (2017)

Section

Pharmaceutical chemistry and pharmacognosy

License

Copyright (c) 2017 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).